About Redbud Medicine
Redbud Medicine is a company based in Beijing (China) founded in 2019. It operates as a B2B. Redbud Medicine has raised $10 million across 1 funding round from investors including Delian Capital and Juming Venture Capital. Redbud Medicine operates in a competitive market with competitors including OncoTheis, AlphaVax, Lukas Biomedical, DXOCRO and Oncosyne, among others.
- Headquarter Beijing, China
-
Sectors
Agriculture
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 23, 2022
-
Investors
Delian Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Redbud Medicine
Redbud Medicine has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.0M
-
First Round
First Round
(23 Aug 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series A - Redbud Medicine | Valuation | Delian Capital , Juming Venture Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Redbud Medicine
Redbud Medicine has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Delian Capital and Juming Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Redbud Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Redbud Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Redbud Medicine Comparisons
Competitors of Redbud Medicine
Redbud Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OncoTheis, AlphaVax, Lukas Biomedical, DXOCRO and Oncosyne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| domain | founded_year | HQ Location |
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
|
|
| domain | founded_year | HQ Location |
Provides in vitro diagnostic services for oncology research and development.
|
|
| domain | founded_year | HQ Location |
Offers tumoroid-based platforms for cancer drug screening and personalized medicine services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Redbud Medicine
When was Redbud Medicine founded?
Redbud Medicine was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Redbud Medicine located?
Redbud Medicine is headquartered in Beijing, China.
Is Redbud Medicine a funded company?
Redbud Medicine is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Aug 23, 2022.
What does Redbud Medicine do?
Redbud Medicine, established in 2019, excels in providing healthcare solutions, advancing biotech innovations, regulatory services, and rd support. Offers comprehensive services in regulatory affairs, RD, data management, and statistical analysis for healthcare. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Who are the top competitors of Redbud Medicine?
Redbud Medicine's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.
Who are Redbud Medicine's investors?
Redbud Medicine has 2 investors. Key investors include Delian Capital, and Juming Venture Capital.